2-(3-Chloro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

2-Bromo-N-(tert-butoxycarbonyl)benzylamine>98.0%(GC)5g

Dichloroacetonitrile>98.0%(GC)500g

5-Methyl-1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 97%, 25g

5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethylisoxazole-3-carboxamide, 98%, 100mg

Methyl 5-chloro-2-iodobenzoate, 95.0%, 5g

3-Chloro-2,4-difluorobenzyl bromide, 5g

Methyl 4-amino-3-methyl-1H-pyrazole-5-carboxylate, 97.0%, 100mg

4-Cyano-3-(trifluoromethyl)phenylisothiocyanate, 98.0%, 5g

Ethyl 2-(2-chloropyridin-3-yl)-2-oxoacetate, 95.0%, 1g

Acide de tungstène, min 99 %, pa, 25 g, emballage plastique.

Anti-GT1a Monoclonal Antibody1vial

N-(Trimethylsilyl)morpholine, 98%, 25g